Skip to main
DCTH
DCTH logo

Delcath Systems (DCTH) Stock Forecast & Price Target

Delcath Systems (DCTH) Analyst Ratings

Based on 8 analyst ratings
Strong Buy
Strong Buy 75%
Buy 13%
Hold 13%
Sell 0%
Strong Sell 0%

Bulls say

Delcath Systems Inc. is projected to increase its total revenues significantly, anticipating a rise from $82.3 million in 2025 to $338.7 million by 2032, indicating robust long-term growth potential. The company has demonstrated consistent quarter-over-quarter growth in HEPZATO-related revenue since its launch, with fourth-quarter 2024 revenues anticipated to reach $13.7 million, reflecting a noteworthy 37% increase from the previous quarter. Additionally, ongoing site activations and expected steady growth in the European market support a strong pipeline, further enhancing the positive outlook for Delcath Systems's financial performance.

Bears say

Delcath Systems has faced persistent financial challenges, including ongoing operational losses and negative cash flows, which raise concerns about its sustainability and ability to fund future growth initiatives. Additionally, the company’s reliance on a single product for revenue generation exposes it to significant risks, particularly in terms of market competition and regulatory scrutiny. The financial reports indicate a lack of diversified revenue streams, contributing to uncertainty regarding the company’s long-term viability and enhancing the negative outlook on its stock.

Delcath Systems (DCTH) has been analyzed by 8 analysts, with a consensus rating of Strong Buy. 75% of analysts recommend a Strong Buy, 13% recommend Buy, 13% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Delcath Systems and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Delcath Systems (DCTH) Forecast

Analysts have given Delcath Systems (DCTH) a Strong Buy based on their latest research and market trends.

According to 8 analysts, Delcath Systems (DCTH) has a Strong Buy consensus rating as of Jul 1, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $19.41, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $19.41, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Delcath Systems (DCTH)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.